257
Views
2
CrossRef citations to date
0
Altmetric
Original Article

First trimester serum levels of the soluble transcobalamin receptor, holo-transcobalamin, and total transcobalamin in relation to preeclampsia risk

, , &
Pages 641-644 | Received 15 Apr 2016, Accepted 28 Aug 2016, Published online: 04 Oct 2016

References

  • Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011;123:2856–69.
  • Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7.
  • Zakiyah N, Postma MJ, Baker PN, van Asselt AD, Consortium IM. Pre-eclampsia diagnosis and treatment options: a review of published economic assessments. Pharmacoeconomics 2015;33:1069–82.
  • Adu-Bonsaffoh K, Oppong SA, Binlinla G, Obed SA. Maternal deaths attributable to hypertensive disorders in a tertiary hospital in Ghana. Int J Gynaecol Obstet 2013;123:110–3.
  • von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143–8.
  • Pluta R, Ulamek-Koziol M, Furmaga-Jablonska W, Czuczwar SJ. Preeclampsia in the 21st century: unresolved questions concerning etiology. Nutrition 2015;31:1179–81.
  • Takahashi K, Ohkuchi A, Suzuki H, Usui R, Kuwata T, Shirasuna K, Matsubara S, Suzuki M. Biophysical interaction between blood pressure and uterine artery Doppler for the occurrence of early-onset preeclampsia: a prospective cohort study. Pregnancy Hypertens 2013;3:270–7.
  • Garcia-Tizon Larroca S, Tayyar A, Poon LC, Wright D, Nicolaides KH. Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30–33 weeks’ gestation. Fetal Diagn Ther 2014;36:9–17.
  • Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Dominguez C, Llurba E, Gratacos E. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors. Prenat Diagn 2015;35:183–91.
  • Pepper MR, Black MM. B12 in fetal development. Semin Cell Dev Biol 2011;22:619–23.
  • Greibe E, Andreasen BH, Lildballe DL, Morkbak AL, Hvas AM, Nexo E. Uptake of cobalamin and markers of cobalamin status: a longitudinal study of healthy pregnant women. Clin Chem Lab Med 2011;49:1877–82.
  • Nielsen MJ, Rasmussen MR, Andersen CB, Nexo E, Moestrup SK. Vitamin B12 transport from food to the body’s cells – a sophisticated, multistep pathway. Nat Rev Gastroenterol Hepatol 2012;9:345–54.
  • Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin. Blood 2009;113:186–92.
  • Sysel AM, Valli VE, Nagle RB, Bauer JA. Immunohistochemical quantification of the vitamin B12 transport protein (TCII), cell surface receptor (TCII-R) and Ki-67 in human tumor xenografts. Anticancer Res 2013;33:4203–12.
  • Arendt JF, Quadros EV, Nexo E. Soluble transcobalamin receptor, sCD320, is present in human serum and relates to serum cobalamin – establishment and validation of an ELISA. Clin Chem Lab Med 2012;50:515–9.
  • Bottomley C, Bourne T. Dating and growth in the first trimester. Best Pract Res Clin Obstet Gynaecol 2009;23:439–52.
  • Shojania AM. Folic acid and vitamin B12 deficiency in pregnancy and in the neonatal period. Clin Perinatol 1984;11:433–59.
  • Koebnick C, Heins UA, Dagnelie PC, Wickramasinghe SN, Ratnayaka ID, Hothorn T, Pfahlberg AB, Hoffmann I, Lindemans J, Leitzmann C. Longitudinal concentrations of vitamin B(12) and vitamin B(12)-binding proteins during uncomplicated pregnancy. Clin Chem 2002;48:928–33.
  • Murphy MM, Molloy AM, Ueland PM, Fernandez-Ballart JD, Schneede J, Arija V, Scott JM. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J Nutr 2007;137:1863–7.
  • Refsum H, Johnston C, Guttormsen AB, Nexo E. Holotranscobalamin and total transcobalamin in human plasma: determination, determinants, and reference values in healthy adults. Clin Chem 2006;52:129–37.
  • Abuyaman O, Andreasen BH, Kronborg C, Vittinghus E, Nexo E. The soluble receptor for vitamin B12 uptake (sCD320) increases during pregnancy and occurs in higher concentration in urine than in serum. PLoS One 2013;8:e73110. doi: 10.1371/journal.pone.0073110.
  • Abuyaman O, Nexo E. The soluble transcobalamin receptor (sCD320) is present in cerebrospinal fluid and correlates to dementia-related biomarkers tau proteins and amyloid-beta. Scand J Clin Lab Invest 2015;75:514–8.
  • Nexo E, Christensen AL, Petersen TE, Fedosov SN. Measurement of transcobalamin by ELISA. Clin Chem 2000;46:1643–9.
  • Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 2002;48:561–2.
  • Morkbak AL, Heimdal RM, Emmens K, Molloy A, Hvas AM, Schneede J, Clarke R, Scott JM, Ueland PM, Nexo E. Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project. Clin Chem Lab Med 2005;43:1058–64.
  • Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of non-severe preeclampsia. Am J Obstet Gynecol 2003;189:391–4.
  • Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001;185:781–5.
  • Obeid R, Morkbak AL, Munz W, Nexo E, Herrmann W. The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birth. Clin Chem 2006;52:263–9.
  • Morkbak AL, Hvas AM, Milman N, Nexo E. Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. Haematologica 2007;92:1711–2.
  • Hure AJ, Collins CE, Smith R. A longitudinal study of maternal folate and vitamin B12 status in pregnancy and postpartum, with the same infant markers at 6 months of age. Matern Child Health J 2012;16:792–801.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.